Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types

Author:

McCormack Clare P.1ORCID,Yan Ada W. C.2ORCID,Brown Jonathan C.2ORCID,Sukhova Ksenia2ORCID,Peacock Thomas P.2ORCID,Barclay Wendy S.2ORCID,Dorigatti Ilaria1

Affiliation:

1. MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK

2. Department of Infectious Disease, Imperial College London, London, UK

Abstract

We use viral kinetic models fitted to viral load data from in vitro studies to explain why the SARS-CoV-2 Omicron variant replicates faster than the Delta variant in nasal cells, but slower than Delta in lung cells, which could explain Omicron's higher transmission potential and lower severity. We find that in both nasal and lung cells, viral infectivity is higher for Omicron but the virus production rate is higher for Delta, with an estimated approximately 200-fold increase in infectivity and 100-fold decrease in virus production when comparing Omicron with Delta in nasal cells. However, the differences are unequal between cell types, and ultimately lead to the basic reproduction number and growth rate being higher for Omicron in nasal cells, and higher for Delta in lung cells. In nasal cells, Omicron alone can enter via a TMPRSS2-independent pathway, but it is primarily increased efficiency of TMPRSS2-dependent entry which accounts for Omicron's increased activity. This work paves the way for using within-host mathematical models to understand the transmission potential and severity of future variants.

Funder

Imperial College Research Fellowship

Medical Research Council/UK Research and Innovation

MRC Centre for Global Infectious Disease Analysis

Wellcome Trust and Royal Society

Publisher

The Royal Society

Subject

Biomedical Engineering,Biochemistry,Biomaterials,Bioengineering,Biophysics,Biotechnology

Reference63 articles.

1. WHO. 2021 Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern . WHO. See https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.

2. GISAID. 2022 GISAID-hCov19 Variants . GISAID. See https://gisaid.org/hcov19-variants/.

3. WHO. 2021 Tracking SARS-CoV-2 variants. WHO. See https://www.who.int/activities/tracking-SARS-CoV-2-variants.

4. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

5. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3